Sernova says five diabetes patients have now been taken off insulin after 'cell pouch' therapy

Lei Lei Wu

News Reporter

Five patients with type 1 diabetes have stopped taking insulin after getting Sernova’s cell transplant treatment, the Canadian biotech reported Monday …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sernova says five diabetes patients have now been taken off insulin after 'cell pouch' therapy

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ser­no­va says five di­a­betes pa­tients have now been tak­en off in­sulin af­ter 'cell pouch' ther­a­py

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Sernova says five diabetes patients have now been taken off insulin after 'cell pouch' therapy